EA199900609A1 - Способ и фармацевтическая композиция для доставки железа у пациентов, получающих гемодиализ и перитонеальный диализ - Google Patents

Способ и фармацевтическая композиция для доставки железа у пациентов, получающих гемодиализ и перитонеальный диализ

Info

Publication number
EA199900609A1
EA199900609A1 EA199900609A EA199900609A EA199900609A1 EA 199900609 A1 EA199900609 A1 EA 199900609A1 EA 199900609 A EA199900609 A EA 199900609A EA 199900609 A EA199900609 A EA 199900609A EA 199900609 A1 EA199900609 A1 EA 199900609A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
iron
delivery
peritoneal dialysis
patients receiving
Prior art date
Application number
EA199900609A
Other languages
English (en)
Other versions
EA002479B1 (ru
Inventor
Аджай Гупта
Original Assignee
Аджай Гупта
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/775,595 external-priority patent/US6689275B1/en
Application filed by Аджай Гупта filed Critical Аджай Гупта
Publication of EA199900609A1 publication Critical patent/EA199900609A1/ru
Publication of EA002479B1 publication Critical patent/EA002479B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Способ введения железа пациентам, получающим диализ, осуществляется с помощью вливания неколлоидного соединения трехвалентного железа, растворимого в растворах для гемодиализа или перитонеального диализа, с использованием процесса диализа. Предоставляется фармацевтическая композиция, состоящая, по существу, из раствора для диализа, включающего неколлоидное соединение трехвалентного железа, предпочтительно пирофосфат трехвалентного железа.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900609A 1996-12-31 1997-12-30 Способ и фармацевтическая композиция для доставки железа у пациентов, получающих гемодиализ и перитонеальный диализ EA002479B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/775,595 US6689275B1 (en) 1996-12-31 1996-12-31 Method and pharmaceutical composition for replacing iron losses in dialysis patients
US5531597P 1997-08-07 1997-08-07
PCT/US1997/023719 WO1998029434A1 (en) 1996-12-31 1997-12-30 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients

Publications (2)

Publication Number Publication Date
EA199900609A1 true EA199900609A1 (ru) 1999-12-29
EA002479B1 EA002479B1 (ru) 2002-06-27

Family

ID=26734087

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900609A EA002479B1 (ru) 1996-12-31 1997-12-30 Способ и фармацевтическая композиция для доставки железа у пациентов, получающих гемодиализ и перитонеальный диализ

Country Status (18)

Country Link
EP (1) EP0951470B1 (ru)
JP (2) JP3955639B2 (ru)
AT (1) ATE311180T1 (ru)
AU (1) AU736053B2 (ru)
BR (1) BR9713653B1 (ru)
CA (1) CA2276442C (ru)
DE (1) DE69734781T2 (ru)
DK (1) DK0951470T3 (ru)
EA (1) EA002479B1 (ru)
ES (1) ES2255115T3 (ru)
HK (1) HK1023350A1 (ru)
NO (1) NO317873B1 (ru)
NZ (1) NZ336319A (ru)
PL (1) PL191377B1 (ru)
SI (1) SI20151A (ru)
TR (1) TR199901518T2 (ru)
WO (1) WO1998029434A1 (ru)
YU (1) YU31299A (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
CA2422850C (en) 1999-09-22 2009-03-03 Advanced Renal Technologies High citrate dialysate and uses thereof
DE19951471A1 (de) * 1999-10-26 2001-05-03 Forssmann Wolf Georg Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
US20070148258A1 (en) * 2003-10-28 2007-06-28 O'neill W C Dialysates and methods and systems related thereto
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
SE0400523D0 (sv) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
US7816404B2 (en) * 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
US7658952B2 (en) 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
CN102858351A (zh) * 2010-04-23 2013-01-02 巴克斯特国际公司 减少或防止腹膜透析治疗期间血管钙化的方法和组合物
AU2015200995B2 (en) * 2010-04-23 2016-09-08 Baxter Healthcare S.A. Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
BR112015018549A8 (pt) * 2013-02-01 2018-01-30 Charak Llc métodos de tratamento de deficiência de ferro
JP6578293B2 (ja) * 2013-11-05 2019-09-18 ロックウェル メディカル，インコーポレイテッド 反応性が低下した患者のエリトロポエチン刺激剤の用量を減少させる方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3530216A (en) * 1967-10-05 1970-09-22 Hoffmann La Roche Vitamin compositions comprising riboflavin-5-phosphate and ferric pyrophosphate soluble
US3911915A (en) * 1972-09-05 1975-10-14 Einstein Coll Med Dialytic introduction of maltose into bloodstream
JPS5125238B2 (ru) * 1973-08-14 1976-07-29
US4756838A (en) * 1980-02-21 1988-07-12 Veltman Preston Leonard Preparation of dry dialysate products
JPH0696586B2 (ja) * 1987-03-17 1994-11-30 花王株式会社 ヘキソ−スリン酸第一鉄塩及びその製造法並びにこれを含有する鉄供給剤
JPH0525051A (ja) * 1991-07-19 1993-02-02 Meiji Seika Kaisha Ltd 貧血予防・治療剤
JP3167402B2 (ja) * 1992-02-25 2001-05-21 仙味エキス株式会社 鉄吸収促進組成物

Also Published As

Publication number Publication date
NZ336319A (en) 2000-12-22
CA2276442C (en) 2012-01-17
JP2002531051A (ja) 2002-09-17
EP0951470B1 (en) 2005-11-30
ES2255115T3 (es) 2006-06-16
EA002479B1 (ru) 2002-06-27
NO993235D0 (no) 1999-06-29
DK0951470T3 (da) 2006-03-27
DE69734781T2 (de) 2006-07-20
EP0951470A4 (en) 2003-05-02
WO1998029434A1 (en) 1998-07-09
CA2276442A1 (en) 1998-07-09
PL334437A1 (en) 2000-02-28
SI20151A (sl) 2000-08-31
TR199901518T2 (xx) 1999-12-21
AU5617298A (en) 1998-07-31
YU31299A (sh) 2002-08-12
NO317873B1 (no) 2004-12-27
AU736053B2 (en) 2001-07-26
JP2007106775A (ja) 2007-04-26
JP3955639B2 (ja) 2007-08-08
BR9713653A (pt) 2000-04-11
PL191377B1 (pl) 2006-05-31
JP4753379B2 (ja) 2011-08-24
EP0951470A1 (en) 1999-10-27
ATE311180T1 (de) 2005-12-15
HK1023350A1 (en) 2000-09-08
NO993235L (no) 1999-08-27
DE69734781D1 (de) 2006-01-05
BR9713653B1 (pt) 2013-05-21

Similar Documents

Publication Publication Date Title
EA199900609A1 (ru) Способ и фармацевтическая композиция для доставки железа у пациентов, получающих гемодиализ и перитонеальный диализ
HK1047715A1 (en) Use of high citrate dialysate
IE790952L (en) Acyl-carnitine solutions for haemodialysis
BR9804330A (pt) Solução para diálise transperitoneal.
SG48704A1 (en) Improved amino acid solutions for treatment of peritoneal dialysis patients
PL345959A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
MY125984A (en) Pharmaceutical solutions of levosimendan.
DE60025698D1 (de) Neue dialysemethode
SE9600631D0 (sv) Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
Iest et al. Loss of residual renal function in patients on regular haemodialysis
ES2183417T3 (es) Concentrado para solucion medica y su utilizacion.
NO20002008L (no) Løsning for peritonealdialyse og fremgangsmÕte for fremstilling derav
Bazzato et al. Why the double-bag system still remains the best technique for peritoneal fluid exchange in continuous ambulatory peritoneal dialysis
Nissenson Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing
Liani et al. Gain in Recombinant Human Erythropoietin Dosage with Continuous Intravenous Intradialytic Administration for the Treatment of Anaemia in End-Stage Renal Disease
Popovich et al. Peritoneal membrane plasmapheresis
UA23383A (ru) Способ лечения анемии у больных с терминальной почечной недостаточностью, находящихся на программном гемодиализе
UA33160A (ru) Способ интенсивной терапии параноидной шизофрении
RU96104613A (ru) Способ лечения больных эндокринной офтальмопатией

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MK4A Patent expired

Designated state(s): BY RU